Seres Therapeutics's market cap is currently ―. The company's EPS TTM is $-0.899; its P/E ratio is -0.81; Seres Therapeutics is scheduled to report earnings on May 1, 2024, and the estimated EPS forecast is $-0.34. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	$ 310.00K	$ 126.47M	$ -522.00K	$ 975.00K	$ 3.44M
Gross Profit	$ 310.00K	$ 126.47M	$ -522.00K	$ 975.00K	-
EBIT	$ -44.88M	$ 53.95M	$ -70.26M	$ -68.33M	$ -58.27M
EBITDA	$ -42.80M	$ 55.58M	$ -68.86M	$ -66.54M	$ -56.53M
Net Income Common Stockholders	$ -48.89M	$ 46.55M	$ -71.17M	$ -68.80M	$ -60.00M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 169.91M	$ 229.52M	$ 106.54M	$ 181.34M	$ 233.00M
Total Assets	$ 367.70M	$ 406.39M	$ 270.19M	$ 348.78M	$ 311.87M
Total Debt	$ 212.28M	$ 212.92M	$ 162.71M	$ 162.59M	$ 76.04M
Net Debt	$ 42.37M	$ -16.60M	$ 56.17M	$ -18.75M	$ -156.96M
Total Liabilities	$ 382.82M	$ 383.77M	$ 318.06M	$ 338.00M	$ 244.28M
Stockholders Equity	$ -15.12M	$ 22.61M	$ -47.87M	$ 10.78M	$ 67.58M
Cash Flow	-
Free Cash Flow	$ -61.05M	$ 64.75M	$ -80.65M	$ -56.35M	$ -60.83M
Operating Cash Flow	$ -59.26M	$ 65.98M	$ -76.58M	$ -52.89M	$ -59.58M
Investing Cash Flow	$ -1.80M	$ 10.52M	$ 2.74M	$ 5.93M	$ 40.13M
Financing Cash Flow	$ 1.44M	$ 58.18M	$ 5.66M	$ 4.60M	$ 98.03M

Currency in USD

Seres Therapeutics Earnings and Revenue History

Income Statement >

Seres Therapeutics Debt to Assets

Balance Sheet >

Seres Therapeutics Cash Flow

Cash Flow >

Seres Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing